Search Results - "Jiao, Zicong"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Modeling of senescence-related chemoresistance in ovarian cancer using data analysis and patient-derived organoids by Cai, Xintong, Li, Yanhong, Zheng, Jianfeng, Liu, Li, Jiao, Zicong, Lin, Jie, Jiang, Shan, Lin, Xuefen, Sun, Yang

    Published in Frontiers in oncology (2023)
    “…Ovarian cancer (OC) is a malignant tumor associated with poor prognosis owing to its susceptibility to chemoresistance. Cellular senescence, an irreversible…”
    Get full text
    Journal Article
  2. 2
  3. 3

    SHR-A1811 (antibody-drug conjugate) in advanced HER2-mutant non-small cell lung cancer: a multicenter, open-label, phase 1/2 study by Li, Ziming, Song, Zhengbo, Hong, Wei, Yang, Nong, Wang, Yongsheng, Jian, Hong, Liang, Zibin, Hu, Sheng, Peng, Min, Yu, Yan, Wang, Yan, Jiao, Zicong, Zhao, Kaijing, Song, Ke, Li, You, Shi, Wei, Lu, Shun

    Published in Signal transduction and targeted therapy (15-07-2024)
    “…A dose-escalation and expansion, phase 1/2 study (ClinicalTrials.gov, NCT04818333) was conducted to assess the novel antibody-drug conjugate SHR-A1811 in…”
    Get full text
    Journal Article
  4. 4

    DELFMUT: duplex sequencing-oriented depth estimation model for stable detection of low-frequency mutations by Wu, Guiying, Song, Mengmeng, Wang, Ke, Cui, Tianyu, Jiao, Zicong, Ji, Liyan, Gao, Xuan, Wang, Jiayin, Liu, Tao, Xia, Xuefeng, Fang, Huan, Guan, Yanfang, Yi, Xin

    Published in Briefings in bioinformatics (20-09-2023)
    “…Abstract Duplex sequencing technology has been widely used in the detection of low-frequency mutations in circulating tumor deoxyribonucleic acid (DNA), but…”
    Get full text
    Journal Article